Financials

  • Market Capitalization 660.29 M
  • Employee 808
  • Founded 2006
  • CEO Timothy R Wright
  • Website www.mimedx.com
  • Headquarter Georgia, United States
  • FIGI BBG000RJ6FL5
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
96.25
Relación precio/flujo de caja

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
2710
SLN
Silence Therapeutics Plc - American Depository Share
14.37 USD+6.21%+4.97%+36.47%+193.27%678.93 M USD
2712
ALLO
Allogene Therapeutics, Inc. - Common Stock
1.96 USD-2.00%-10.09%+4.26%+75.00%677.16 M USD
2730
PRME
Prime Medicine, Inc. - Common Stock
3.63 USD+1.11%-0.27%+25.61%+14.51%658.40 M USD
2731
SGMT
Sagimet Biosciences Inc. - Series A Common Stock
10.58 USD+3.12%+2.22%+56.97%+42.78%657.64 M USD

Noticias